News
An abnormal protein normally found in brain cells affected in Parkinson's can move from the gut to the brain, according to new research.
Paul Mayhew-Archer has won an award for his BBC documentary Parkinson's: The Funny side.
A new drug treatment for Parkinson's, opicapone, has launched in the UK. It could prolong the effect of levodopa and reduce the number of tablets required.
New research shows that people recently diagnosed with Parkinson's who are at high or medium risk of cardiovascular disease tend to have more problems with walking and memory.
A new clinical study published in the journal Parkinsonism and Related Disorders links higher caffeine consumption to slower development of Parkinson's symptoms after diagnosis.
Positive results from a trial of ultrasound therapy for treating tremor have been published, with potential benefits for controlling Parkinson's symptoms.
Researchers from the UCL have identified a way to detect Parkinson's through the eyes in a rat model of the condition.
New research suggests that severe head injury, which causes loss of consciousness, could be linked to increased risk of developing Parkinson's.
A year after Duodopa was funded by NHS England we reflect on the importance of campaigning for people affected by Parkinson's and how you can get involved.
7 of the world’s largest pharmaceutical companies have signed up to a ground-breaking new initiative to improve clinical trials for Parkinson's.